SFXN1 and cancer: Various SFXN1 expression groups showed significant enrichment of pathways, with SFXN1 exhibiting somatic gene mutations in cancer-related signaling pathways like RTK-RAS, WNT, NOTCH, Hippo and PI3K which indicates its critical role in cancer development (Fig. 5C, D).